{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:00:45Z","timestamp":1773298845351,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ajog.2016.06.020","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T12:16:22Z","timestamp":1468930582000},"page":"632.e1-632.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at\u00a0two\u00a0United States medical centers"],"prefix":"10.1016","volume":"215","author":[{"given":"Dominika L.","family":"Seidman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Timoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karishma K.","family":"Oza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah L.","family":"Cohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2016.06.020_bib1","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva 2015. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/186275\/1\/9789241509565_eng.pdf?ua=1. Accessed February 1,\u00a02016."},{"key":"10.1016\/j.ajog.2016.06.020_bib2","unstructured":"Centers for Disease Control and Prevention. Pre-exposure prophylaxis for the prevention of HIV infection in the United States\u20142014: a clinical practice guideline. Atlanta, GA 2014. Available at: http:\/\/www.cdc.gov\/hiv\/pdf\/prepguidelines2014.pdf. Accessed February 1,\u00a02016."},{"key":"10.1016\/j.ajog.2016.06.020_bib3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.15585\/mmwr.mm6446a4","article-title":"Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition - United States, 2015","volume":"64","author":"Smith","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2016.06.020_bib4","doi-asserted-by":"crossref","first-page":"e1001608","DOI":"10.1371\/journal.pmed.1001608","article-title":"Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis","volume":"11","author":"Drake","year":"2014","journal-title":"PLoS Me"},{"key":"10.1016\/j.ajog.2016.06.020_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719108325510","article-title":"The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression","volume":"16","author":"Sheffield","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2016.06.020_bib6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/AOG.0b013e3181e00955","article-title":"Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002-2006","volume":"115","author":"Birkhead","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.020_bib7","doi-asserted-by":"crossref","first-page":"c6580","DOI":"10.1136\/bmj.c6580","article-title":"Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study","volume":"341","author":"Humphrey","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2016.06.020_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/COH.0b013e3283636ccb","article-title":"Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges","volume":"8","author":"Nesheim","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.ajog.2016.06.020_bib9","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/QAD.0000000000000298","article-title":"Estimating per-act HIV transmission risk: a systematic review","volume":"28","author":"Patel","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2016.06.020_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jama.2014.8735","article-title":"Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial","volume":"312","author":"Mugo","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2016.06.020_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/QAI.0000000000000413","article-title":"Pregnancy and contraceptive use among women participating in the FEM-PrEP trial","volume":"68","author":"Callahan","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2016.06.020_bib12","series-title":"Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989\u201331 July 2015","year":"2015"},{"key":"10.1016\/j.ajog.2016.06.020_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/QAD.0b013e328352d135","article-title":"Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants","volume":"26","author":"Siberry","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2016.06.020_bib14","doi-asserted-by":"crossref","first-page":"e1001217","DOI":"10.1371\/journal.pmed.1001217","article-title":"Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial","volume":"9","author":"Gibb","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2016.06.020_bib15","unstructured":"Siberry GK, Tierney C, Stranix-Chibanda L, et\u00a0al. Impact of maternal tenofovir use on HIV-exposed newborn bone mineral content. Conference on Retroviruses and Opportunistic Infections, Boston, MA, Feb 22-5,\u00a02016."},{"key":"10.1016\/j.ajog.2016.06.020_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/QAI.0b013e3182a7adb2","article-title":"Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy","volume":"64","author":"Ransom","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2016.06.020_bib17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/INF.0000000000000747","article-title":"Meconium tenofovir concentrations and growth and bone outcomes in prenatally tenofovir exposed HIV-uninfected children","volume":"34","author":"Himes","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajog.2016.06.020_bib18","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to\u00a0reduce perinatal HIV transmission in the United States. Available at: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf. Accessed February 1,\u00a02016."},{"key":"10.1016\/j.ajog.2016.06.020_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2016.06.020_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/cid\/ciu798","article-title":"Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence","volume":"60","author":"Ehrhardt","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2016.06.020_bib21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.AOG.0000446855.78026.21","article-title":"Committee on Gynecologic Practice: preexposure prophylaxis for the prevention of human immunodeficiency virus. Committee Opinion, no.: 595","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.020_bib22","first-page":"1","article-title":"Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services","volume":"54","author":"Smith","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2016.06.020_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/AOG.0000000000001455","article-title":"Integrating preexposure prophylaxis for human immunodeficiency virus prevention into women\u2019s healthcare in the United States","volume":"128","author":"Seidman","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.020_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11904-016-0312-1","article-title":"PrEP as peri-conception HIV prevention for women and men","volume":"13","author":"Heffron","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.ajog.2016.06.020_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10461-009-9558-6","article-title":"HIV risk behaviors in heterosexual partnerships: female knowledge and\u00a0male behavior","volume":"14","author":"Chen","year":"2010","journal-title":"AIDS Behav"},{"key":"10.1016\/j.ajog.2016.06.020_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0956462414531243","article-title":"Risk for HIV following a diagnosis of syphilis, gonorrhoea or chlamydia: 328,456 women in Florida, 2000-2011","volume":"26","author":"Peterman","year":"2015","journal-title":"Int J STD AIDS"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816303593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816303593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:11:08Z","timestamp":1757589068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937816303593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0002937816303593"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2016.06.020","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at\u00a0two\u00a0United States medical centers","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2016.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}